Predictive Factors of Clinical Response to Ustekinumab in Active Crohn's Disease

NCT03351647 · clinicaltrials.gov ↗
COMPLETED
Status
18
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Hospices Civils de Lyon